First-in-Human trial tests implant to stop Cancer's return after surgery
Disease control
Completed
This first-in-human study tested the safety of a special drug-coated membrane placed in the surgical area immediately after removing a recurring or advanced abdominal soft tissue sarcoma. The goal was to see if leaving this slow-release chemotherapy implant where the tumor was co…
Phase: PHASE1 • Sponsor: CEBIOTEX • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC